ZEB1 and breast cancer: Further mechanistic studies reveal that GRHL2 is directly inhibited by ZEB1, which in itself, a direct target for repression by GRHL2 (106), suggesting that GRHL2 and ZEB1 form a double-negative regulatory feedback loop in breast cancer cells.